The Right Time and " Pl ACE": Optimal Management of Perioperative Angiotensin-Converting Enzyme Inhibitors

被引：2
|
作者：
Chopra, Vineet [1 ,2 ]
Wijeysundera, Duminda N. [3 ,4 ,5 ]
机构：
[1] Ann Arbor VA Healthcare Syst, Patient Safety Enhancement Program, Ann Arbor, MI USA
[2] Univ Michigan Hlth Syst, Dept Med, Ann Arbor, MI USA
[3] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada
[4] Toronto Gen Hosp, Dept Anesthesia, Toronto, ON, Canada
[5] Univ Toronto, Toronto, ON, Canada
来源：
JOURNAL OF HOSPITAL MEDICINE | 2014年 / 9卷 / 05期
基金：
加拿大健康研究院;
关键词：
ACUTE KIDNEY INJURY; CARDIOPULMONARY BYPASS; CLINICAL CONSEQUENCES; SYSTEM ANTAGONISTS; NONCARDIAC SURGERY; MORTALITY;
D O I：
10.1002/jhm.2203
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：334 / 336
页数：3
相关论文
共 50 条
  • [21] Association between Angiotensin-Converting Enzyme Inhibitors and Troponin in Acute Coronary Syndrome
    Minuzzo, Luiz
    dos Santos, Elizabete Silva
    Timerman, Ari
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2014, 103 (06) : 513 - 520
  • [22] Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia
    Mortensen, E. M.
    Pugh, M. J.
    Copeland, L. A.
    Restrepo, M. I.
    Cornell, J. E.
    Anzueto, A.
    Pugh, J. A.
    EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (03) : 611 - 617
  • [23] Imbalance Between Pulmonary Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 Activity in Acute Respiratory Distress Syndrome
    Wosten-van Asperen, Roelie M.
    Bos, Albert P.
    Bem, Reinout A.
    Dierdorp, Barbara S.
    Dekker, Tamara
    van Goor, Harry
    Kamilic, Jelena
    van der Loos, Chris M.
    van den Berg, Elske
    Bruijn, Martijn
    van Woensel, Job B.
    Lutter, Rene
    PEDIATRIC CRITICAL CARE MEDICINE, 2013, 14 (09) : E438 - E441
  • [24] Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease
    ElAbd, Rawan
    AlTarrah, Dana
    AlYouha, Sarah
    Bastaki, Hamad
    Almazeedi, Sulaiman
    Al-Haddad, Mohannad
    Jamal, Mohammad
    AlSabah, Salman
    FRONTIERS IN MEDICINE, 2021, 8
  • [25] Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and survival in a cohort of chronic hemodialysis patients
    Higashiuesato, Y
    Tana, T
    Tozawa, M
    Iseki, C
    Iseki, K
    Fukiyama, K
    Takishita, S
    CLINICAL NEPHROLOGY, 2002, 58 (05) : 370 - 375
  • [26] Novel roles of the renal angiotensin-converting enzyme
    Giani, Jorge F.
    Veiras, Luciana C.
    Shen, Justin Z. Y.
    Bernstein, Ellen A.
    Cao, DuoYao
    Okwan-Duodu, Derick
    Khan, Zakir
    Gonzalez-Villalobos, Romer A.
    Bernstein, Kenneth E.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2021, 529
  • [27] Cardiovascular protection by angiotensin-converting enzyme inhibition
    Ferrari, Roberto
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2009, 11 (0E) : E1 - E3
  • [28] Angiotensin-converting enzyme inhibitors predict acute kidney injury during chemoradiation for head and neck cancer
    Spiotto, Michael T.
    Cao, Hongyuan
    Mell, Loren
    Toback, F. Gary
    ANTI-CANCER DRUGS, 2015, 26 (03) : 343 - 349
  • [29] Survival impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in head and neck cancer
    Stokes, William A.
    Molina, Elizabeth
    McDermott, Jessica D.
    Morgan, Rustain L.
    Bickett, Thomas
    Fakhoury, Kareem R.
    Amini, Arya
    Karam, Sana D.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (11): : 3255 - 3275
  • [30] Cardiac mortality in users of olmesartan, other angiotensin-receptor blockers and angiotensin-converting enzyme inhibitors
    Walker, Alexander M.
    Liang, Caihua
    Clifford, C. Robin
    Parker, Crawford
    Feldman, Allen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (04) : 348 - 356
12345